TSC1 Protein — Hamartin

📖 Wiki Page

protein1180 wordssynced 2026-04-02

TSC1 Protein — Hamartin

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">TSC1 Protein — Hamartin</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Hamartin (TSC1)</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[TSC1](/genes/tsc1)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>[Q9UMX0](https://www.uniprot.org/uniprot/Q9UMX0)</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~130 kDa (1164 amino acids)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cytoplasm, lysosomes, endosomes</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>TSC family</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>TSC1, Hamartin, KCAA0025</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Ubiquitous; highest in brain, heart, kidney</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/atherosclerosis" style="color:#ef9a9a">Atherosclerosis</a>, <a href="/wiki/autism" style="color:#ef9a9a">Autism</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">146 edges</a></td>
</tr>
</table>

...

TSC1 Protein — Hamartin

Introduction

TSC1 (Hamartin) is a tumor suppressor protein that forms a critical complex with TSC2 (tuberin) to regulate the [mTORC1](/proteins/mtorc1-protein) signaling pathway. The TSC1-TSC2 complex acts as a GTPase-activating protein (GAP) for [Rheb](/proteins/rheb-protein), controlling the activation of mTORC1 and downstream anabolic processes including protein synthesis, lipid metabolism, and autophagy. In the nervous system, proper TSC1 function is essential for neuronal morphology, synaptic plasticity, and cellular homeostasis. Dysregulation of TSC1-mTOR signaling has been implicated in [Tuberous Sclerosis Complex](/diseases/tuberous-sclerosis), [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), and [epilepsy](/diseases/epilepsy).

:: infobox .infobox-protein
::

Overview

The TSC1-TSC2 complex is a central regulator of cellular anabolic metabolism through its control of mTORC1 signaling. TSC1 (hamartin) and TSC2 (tuberin) form a heterodimeric complex that localizes primarily to the cytoplasm and lysosomal membranes, where it senses cellular nutrient, energy, and growth factor status.

The core function of the TSC1-TSC2 complex is:

Rheb GAP Activity: TSC2 has intrinsic GAP activity toward [Rheb](/proteins/rheb-protein), converting active Rheb-GTP to inactive Rheb-GDP

mTORC1 Inhibition: Inactive Rheb cannot activate mTORC1, thereby inhibiting protein synthesis and other anabolic processes

Nutrient Sensing: The TSC1-TSC2 complex integrates signals from multiple pathways including [AMPK](/proteins/ampk-protein), [AKT](/proteins/akt1-protein), and [ERK](/proteins/erk-protein)

Autophagy Regulation: TSC1-TSC2 controls autophagy through mTORC1-dependent and independent mechanisms

In neurons, TSC1-mTOR signaling regulates:

Synaptic Plasticity: Local protein synthesis at synapses is controlled by mTORC1 activity
Neuronal Morphogenesis: mTORC1 controls dendritic arborization and axonal growth
Cellular Homeostasis: Autophagy regulation maintains neuronal health
Metabolism: Lipid and protein synthesis are balanced with degradation

Structure

TSC1 is a 1164-amino acid protein with a molecular weight of approximately 130 kDa. Key structural features include:

N-terminal Hamartin Homology Domain: Mediates TSC1-TSC2 binding
Coiled-coil Domains: Enable protein-protein interactions
Tuberous Sclerosis Homology Domain: Mediates localization to lysosomes and endosomes
C-terminal Domain: Interacts with signaling proteins

The structure of TSC1 is primarily alpha-helical, with multiple coiled-coil regions that mediate dimerization with TSC2. The TSC1-TSC2 interaction is stable, with both proteins required for proper cellular localization and function.

Normal Function

TSC1-TSC2 Complex Formation

The TSC1-TSC2 complex is the functional unit:

Heterodimer Formation: TSC1 and TSC2 associate through their N-terminal coiled-coil domains

Complex Stability: TSC1 stabilizes TSC2, preventing its proteasomal degradation

Subcellular Localization: The complex localizes to lysosomes through interactions with the TSC1 C-terminus

Signal Integration: Multiple signaling pathways regulate the complex

mTORC1 Regulation

The TSC1-TSC2 complex controls [mTORC1](/proteins/mtorc1-protein) through Rheb:

Rheb GAP Activity: TSC2's GAP domain converts Rheb-GTP to Rheb-GDP

mTORC1 Activation: Rheb-GTP directly activates mTORC1

Growth Factor Signaling: [AKT](/proteins/akt1-protein) phosphorylates and inhibits TSC2, promoting mTORC1 activation

Energy Sensing: [AMPK](/proteins/ampk-protein) activates TSC1-TSC2 during energy stress, inhibiting mTORC1

Autophagy Regulation

The TSC1-TSC2 complex regulates [autophagy](/mechanisms/autophagy):

mTORC1-Dependent: mTORC1 inhibits autophagyinitiation through ULK1 phosphorylation

mTORC1-Independent: TSC1 can directly regulate autophagy components

Lysosomal Function: TSC1 localizes to lysosomes where autophagy occurs

Neuronal Autophagy: Neurons rely on basal autophagy for protein quality control

Neuronal Functions

In neurons, TSC1-mTOR signaling regulates:

Local Translation: mTORC1 localizes to dendritic spines for activity-dependent translation

Synaptic Plasticity: Long-term potentiation (LTP) and depression (LTD) require mTORC1 activity

Dendrite Morphogenesis: mTORC1 controls dendritic arbor complexity

Axon Guidance: Growth cone dynamics are regulated by TSC1-mTOR

Role in Disease

Tuberous Sclerosis Complex

[TSC](/diseases/tuberous-sclerosis) is caused by heterozygous TSC1 or TSC2 mutations:

Autosomal Dominant: Mutations in either TSC1 or TSC2 cause the disease

Hamartomas: Benign tumors grow in multiple organs including brain, skin, and kidneys

Neurological Symptoms: Epilepsy, intellectual disability, and autism are common

SEGAs: Subependymal giant cell astrocytomas are a serious complication

The neurological manifestations of TSC reflect the essential role of TSC1 in neuronal development and function.

Alzheimer's Disease

TSC1-mTOR signaling is dysregulated in AD:

mTORC1 Hyperactivity: AD brains show increased mTORC1 activity despite decreased upstream signaling

Autophagy impairment: Autophagy is impaired in AD, with accumulated autophagic vacuoles

Synaptic Protein Synthesis: Dysregulated local translation may contribute to synaptic loss

Amyloid-β Effects: [Amyloid-β](/proteins/amyloid-beta) can alter TSC1-mTOR signaling

Therapeutic strategies targeting mTORC1 in AD are under investigation, with rapamycin showing promise in preclinical models.

Parkinson's Disease

TSC1-mTOR signaling may be affected in [PD](/diseases/parkinsons-disease):

Alpha-Synuclein: mTORC1 regulates [alpha-synuclein](/proteins/alpha-synuclein) synthesis

Autophagy: PD is associated with autophagy deficits

Mitochondrial Dysfunction: mTORC1 regulates mitochondrial quality control

L-DOPA Response: Dysregulated mTORC1 may affect L-DOPA response

Epilepsy

TSC1 mutations cause epilepsy through multiple mechanisms:

Cortical Dysplasia: Abnormal neuronal migration in TSC

mTORC1 Hyperactivity: Excess mTORC1 activity causes hyperexcitability

Synaptic Dysfunction: Altered synaptic protein synthesis

mTOR Inhibitors: Rapamycin and related drugs reduce seizure frequency

Therapeutic Targeting

Current therapeutic strategies include:

mTOR Inhibitors: [Rapamycin](/proteins/rapamycin), [everolimus](/proteins/everolimus), and related rapalogs

Dual mTOR Inhibitors: [Torin1](/proteins/torin1) and [AZD8055](/proteins/azd8055) inhibit both mTORC1 and mTORC2

Autophagy Inducers: Trehalose and other autophagy-inducing compounds

Gene Therapy: TSC1 gene replacement is theoretically possible

Rapamycin and everolimus are FDA-approved for TSC and have shown efficacy in reducing seizure frequency and tumor size.

Interacting Proteins

TSC1 interacts with:

[TSC2 (Tuberin](/proteins/tsc2-protein)) — The TSC complex partner
[Rheb](/proteins/rheb-protein) — GAP target
[mTORC1](/proteins/mtorc1-protein) — Downstream effector
[AMPK](/proteins/ampk-protein) — Energy sensor
[AKT1](/proteins/akt1-protein) — Growth factor signaling
[ERK1/2](/proteins/erk-protein) — MAPK signaling
[ULK1](/proteins/ulkl1-protein) — Autophagy initiation

Key Publications

[Huang & Manning, The TSC1-TSC2 complex in mTOR (2003)](https://pubmed.ncbi.nlm.nih.gov/12773155/) — Classic review

[Kwiatkowski & Manning, Tuberous sclerosis (2005)](https://pubmed.ncbi.nlm.nih.gov/16077714/) — TSC pathogenesis

[Tschoner et al., TSC1 in neuronal morphology (2014)](https://pubmed.ncbi.nlm.nih.gov/24711541/) — Neural functions

[Zhang & Zhang, TSC1 and mTOR in neurodegeneration (2017)](https://pubmed.ncbi.nlm.nih.gov/28102844/) — Neurodegeneration

[Curatolo & Moavero, TSC1 mutations in epilepsy (2019)](https://pubmed.ncbi.nlm.nih.gov/31178756/) — Epilepsy in TSC

[Wang & Tang, TSC-mTOR in AD (2020)](https://pubmed.ncbi.nlm.nih.gov/32845176/) — AD connection

Cross-Links

[TSC1 Gene](/genes/tsc1) — Gene page
[TSC2 Protein](/proteins/tsc2-protein) — Complex partner
[mTORC1 Signaling](/mechanisms/mtor-signaling) — Pathway page
[Tuberous Sclerosis](/diseases/tuberous-sclerosis) — Disease page
[Alzheimer's Disease](/diseases/alzheimers-disease) — Disease page
[Parkinson's Disease](/diseases/parkinsons-disease) — Disease page
[Autophagy](/mechanisms/autophagy) — Pathway page

References

[Huang & Manning, The TSC1-TSC2 complex in mTOR (2003)](https://pubmed.ncbi.nlm.nih.gov/12773155/)

[Kwiatkowski & Manning, Tuberous sclerosis (2005)](https://pubmed.ncbi.nlm.nih.gov/16077714/)

[Tschoner et al., TSC1 in neuronal morphology (2014)](https://pubmed.ncbi.nlm.nih.gov/24711541/)

[Zhang & Zhang, TSC1 and mTOR in neurodegeneration (2017)](https://pubmed.ncbi.nlm.nih.gov/28102844/)

[Curatolo & Moavero, TSC1 mutations in epilepsy (2019)](https://pubmed.ncbi.nlm.nih.gov/31178756/)

[Wang & Tang, TSC-mTOR in AD (2020)](https://pubmed.ncbi.nlm.nih.gov/32845176/)

📖 View canonical wiki page →

TSC1 Protein — Hamartin

TSC1 Protein — Hamartin

Introduction

TSC1 Protein — Hamartin

Introduction

Overview

Structure

Normal Function

TSC1-TSC2 Complex Formation

mTORC1 Regulation

Autophagy Regulation

Neuronal Functions

Role in Disease

Tuberous Sclerosis Complex

Alzheimer's Disease

Parkinson's Disease

Epilepsy

Therapeutic Targeting

Interacting Proteins

Key Publications

Cross-Links

See Also

References